medigraphic.com
ISSN 0035-0052 (Impreso)

2000, Número 3

<< Anterior Siguiente >>

Rev Mex Pediatr 2000; 67 (3)


Meningitis bacteriana: conceptos prácticos para su abordaje

Coria LJJ, Espinoza OMM, Gómez BD

Idioma: Español
Referencias bibliográficas: 42
Paginas: 133-141
Archivo PDF: 444.40 Kb.


RESUMEN

Incluso hasta la introducción de sulfonamidas y penicilinas (hace poco más de 50-60 años), la meningitis bacteriana en muchos casos era una enfermedad mortal. Desde entonces ésta ha podido ser curable, con variables en sus porcentajes de morbilidad y mortalidad de acuerdo a los diferentes patógenos (ejemplo: Streptococcus pneumoniae, Haemophilus influenzae tipo b, Neisseria meningitidis, Streptoccocus del grupo B, Escherichia coli, Pseudomonas spp, Staphylococcus aureus y epidermidis, etc.), y tipo de pacientes (neonatos, lactantes,inmunosuprimidos, neuroquirúrgicos, con traumatismo de cráneo, adultos, ancianos, etc.). Después de la primera punción lumbar realizada por Quincke en 1891 y la primera identificación de un patógeno por Heubner en 1896, un gran número de estudios clínicos y posteriormente terapéuticos se han publicado. A pesar de esto puede resultar difícil evaluar a un paciente con sospecha de meningitis bacteriana y más aún el iniciar una terapéutica antimicrobiana adecuada.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. McCraken HG Jr. Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J 1992; 11: 169-174.

  2. López LP, Gómez BD, Sequeira SM, Moreno MJ. Actualidades en meningitis bacteriana. Infectología 1990; 10(2): 75-89.

  3. Philips FC. Epidemiology of bacterial meningitis. Pediatr Am 1994; 23(2): 67-68.

  4. Gómez BD, Jimémez VA, Rodríguez SR. Meningitis bacteriana. Parte 1. Bol Med Hosp Infant Méx 1998; 5(10): 599-622.

  5. Murray CJL, López AD. Global Health Statistics. A Compendium of incidence, prevalence and mortality estimates for over conditions. Vol II Harvard University Press 1996.

  6. Salih MA, Khaleefa OH, Bushara M et al. Long term sequelae of childhood acute bacterial meningitis in a developing country. Scand J Infect Dis 1991; 23: 175-182.

  7. Committee on Infectious Diseases/AAP. Therapy for Children with Invasive Pneumococcal Infection. Peditrics 1997; 99(2): 289-299.

  8. Hussey G. The management of bacterial meningitis in developing countries-issues of antibiotic therapy. Report to WHO Meeting, geneva 1997: 17-20.

  9. Center for disease control. Progress toward elimination of Haemophilus influenzae type b disease among infants and children in the United States 1987-95. MMWR. 1996; 45(42): 901-906.

  10. Adams WG, Deaver KA, Cochi SL et al. Decline in childhood Haemopphilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-226.

  11. Sáes-Llorens X, Ramilo O, Mustafa M, Mertsola J, McCracken GH Jr. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 1990; 116: 671-684.

  12. Tunkle AR, Wispelwey B, Scheldl WM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med 1990; 112: 610-623.

  13. Wientzen RL, McCracken GH Jr. Pathogenesis and management of neonatal sepsis and meningitis. Curr Probl Pediatr 1977;

  14. 8: 3-61.

  15. Gladstone Mi, Ehrenkraz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990; 9: 819-825.

  16. Solorzano SF, Echaniz AG, Conde GC, Conde Glez CJ, Calderon JE, Arredondo Garcia JL, Beltran ZM. Cervicovaginal carriage of group B streptococci among Mexican women. J Infect Dis 1989; 159: 1003-1004.

  17. Davey PG, Cruikshank JK, McManus IC et al. Bacterial meningitis: Ten years’ experience. J Hyg 1982; 89: 383-401.

  18. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D. Pneumococcus study group: Invasive disease due Streptococcus pneumoniae in area with a high rate of relative penicillin resistance. J Infect Dis 1987; 156: 732-735.

  19. Wubbel L, McCracken GH Jr. Management of bacterial meningitis 1998. Pediatrics in Review 1998; 19(3): 78-84.

  20. Feigin DR, McCracken GH Jr, Klein OJ. Diagnosis and management of meningitis. Pediatr Infect Dis J 1992; 11(9): 785-814.

  21. Saez-Llorens X, McCracken GH Jr. Bacterial meningitis. In: Katz SL, Gershon AA, Hotez PJ, eds. Krugman’s Infectious Diseases of Children. St. Lous, Mo: CV Mosby 1998: 265-279.

  22. Kline MW. Review of recurrent bacterial meningitis. Pediatr Infect Dis J 1989; 8: 630-634.

  23. Peltola H, Antilla M, Renkonen OV. Randomized comparison of chloramphenicol, ampicilin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet 1989; 1: 1281-1287.

  24. Kacica AM, Lepow LM. Meningitis: Clinical Presentation and Workup. Pediatr Ann 1994; 23(2): 69-75.

  25. Stutman HR, Marks MI. Bacterial meningitis in children: diagnosis and therapy. Clin Pediatr 1987; 26:431-438.

  26. Bonadio AW. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J 1992; 11(6): 423-432.

  27. Radetsky M. Duration of treatment in bacterial meningitis: a historical inquiry. Pediatric Infect Dis 1990; 9: 2-9.

  28. Wood JAJ. Treatment of bacterial meningitis. N Engl J Med 1997; 336(10): 709-716.

  29. Paris MM, Hickey SM, Uscher MI, Shelton S. Olsen KD, McCraken GH Jr. Effect of dexametaxone on therapy of experimental penicillin-and cephalosporin-resistan pneumococcal menigitis. Antimicrob Agents Chemother 1994; 38: 1320-1324.

  30. Difabio JL, Homma A, DeQuadros C. Pan American Healh Organization Epidemiological Surveillance Network for Streptococcus pneumoniae. Microb Drug Resis 1997; 3(2): 131-157.

  31. Schaad UB, Suter S, Gianella-Borradori A et al. A comparison of ceftriaxone and cefuroxime for treatment of bacterial meningitis in children. N Engl J Med 1990; 322: 141-147.

  32. Klein OJ. Antimicrobial treatment and prevention of meningitis. Pediatr Ann 1994; 23(2): 7681.

  33. American Academy of Pediatrics. Red Book report of the committee on Infectious Diseases. 24th Edition. AAP 1997: 410-419.

  34. Viladrich PF et al. Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 1986; 146: 2380-2382.

  35. Macfarlane JT et al. Single injection treatment of meningococcal meningitis I. Long-acting penicillin. Trans Royal Soc Trop Med Hygiene 1979; 73: 693-97.

  36. Sakata Y, McCraken G, Thomas ML, Olsen KD. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicilin and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antim Agents chemo 1984; 25(1): 29-32.

  37. Ngu JL, Youmbissi TJ, Mbanya C. Short-duration ceftriaxone versus ampicillin and chloramphenicol in the treatment of bacterial meningitis in children in Yaounde. XIXth Int Congr Pediatr, Paris 1986, abstr 301. Munich, Futuramed 1986.

  38. Lin T-Z, Chrane DF, Nelson JD, McCracken GH. Seven days of ceftriaxone therapy is as effective ten en day’s treatment for bacterial meningitis. JAMA 1985; 253: 3559-3563.

  39. Girgis NI et al. Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis. Scand J Infect Dis 1988; 20: 613-617.

  40. Martin E et al. Short course single daily ceftriaxone monotherapy for acute meningitis in children. Results of a Swiss multicenter study. Infection 1990; 18(2): 70-77.

  41. Litsar I et al. ¿Five days of antibacterial therapy for bacterial meningitis in children? Infection 1995; 23(2): 113-118.

  42. Kornelisse RF et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21: 1390-1397.




2020     |     www.medigraphic.com